Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Pathology is not destiny. So say the more than 1200 brains autopsied so far as part of the Rush Memory and Aging Project and the Religious Orders Study, a pair of massive prospective studies that have tracked the cognitive status of nearly 3000 elders for about 2 decades (Bennett DA et al. Curr Alzheimer Res. 2012;9:646-663, and Bennett DA et al. Curr Alzheimer Res. 2012;9:628-645).
Autopsies showed that some mentally spry participants had extensive signs of cellular neuropathologies such as Lewy bodies or those related to Alzheimer or vascular disease. But others with substantial cognitive decline in their later years had few signs of these cellular abnormalities, explained David Bennett, MD, director of the Rush Alzheimer’s Disease Center at Rush University in Chicago and lead investigator of the studies. In fact, these overt cellular pathologies accounted for only about half of the cognitive decline documented, revealing a disconnect with the study participants’ cognitive status. (Boyle PA et al. Ann Neurol. 2013;74:478-489).
Kuehn BM. The Brain Fights Back: New Approaches to Mitigating Cognitive Decline. JAMA. 2015;314(23):2492–2494. doi:10.1001/jama.2015.15390
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: